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Purpose: To develop computer models to mimic the impedance-controlled pulsing protocol 
implemented in RF generators used for clinical practice of radiofrequency ablation (RFA), 
and to assess the appropriateness of the models by comparing the computer results with those 
obtained in previous experimental studies. 
Methods: A 12-minute RFA was modeled using a cooled electrode (17G, 3 cm tip) inserted 
in hepatic tissue. The short (transverse) diameter of the coagulation zone was assessed under 
in vivo (with blood perfusion and considering clamping) and ex vivo (at 21ºC) conditions. 
The computer results obtained by programming voltage pulses were compared with current 
pulses. 
Results: The differences between voltage and current pulses protocol were noticeable: using 
current instead of voltage allows larger coagulation zones to be created, due to the higher 
energy applied by current pulses. If voltage pulses are employed, the model can accurately 
predict number of roll-offs, although the waveform of the applied power is clearly not 
realistic. If current voltages are employed, the applied power waveform matches well with 
those reported experimentally, but there are significantly fewer roll-offs. Our computer 
results were overall into the ranges of experimental ones.  
Conclusions: The proposed models reproduce reasonably well the electrical-thermal 
performance and coagulation zone size obtained during an impedance-controlled pulsing 
protocol. 
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Radiofrequency ablation (RFA) is a minimally invasive technique widely employed to 
destroy tumors [1] in which radiofrequency (RF) electrical currents (≈500 kHz) are delivered 
to the tissue by means of an electrode in order to selectively heat the tumor by raising its 
temperature over 50ºC. The aim of RFA is to produce a successful coagulation zone in terms 
of the tumor being completely surrounded by a zone in which tissue has been irreversibly 
destroyed by heat. During heating, the charring and dehydration of the tissue around the 
electrode produces an electrical impedance increase (a phenomenon known as roll-off), 
which significantly reduces energy diffusion and limits coagulation zone size. Changing the 
power delivery protocol and electrode design are the primary ways of overcoming this 
limitation and achieving larger coagulation zones. Probably the most clinically used approach 
in tumor RFA is using a needle-like cooled electrode combined with an impedance-controlled 
pulsing protocol [2]. This protocol increases coagulation zone size, since periods of low 
current deposition alternate with higher peak current, which allows the tissue near the 
electrode to cool while the deeper tissue is heated [3]. RF power is switched off once the 
impedance exceeds a threshold (usually 2030 Ω higher than the initial value) and is switched 
on again after a few seconds. This protocol is followed up to the end of the pre-set ablation 
time. 
Numerous modeling studies have been published on RFA with needle-like cooled 
electrodes [4-11] although they rarely provide sufficient details of the pulsing protocol used. 
In some cases, the model simply reduces the applied voltage to the maximum level at which 
no tissue is heated beyond 100ºC [4-6]. Others do not provide details of the RF power 
delivery protocol [7], so we cannot be sure whether an impedance-controlled pulsing protocol 
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was really modeled. In others, although the authors state that the impedance-controlled 
pulsing protocol was implemented [8-11], the results do not contain details of the evolution 
of the electrical variables (voltage and impedance), which would show whether the protocol 
had been realistically modeled. In a recent modeling study, Zhang et al [12] implemented an 
impedance-controlled protocol based on voltage pulses, trying to mimic the actual algorithm 
used by RF generators employed in clinical practice. However, some issues still need to be 
included in the computer models. Firstly, it is known that commercial RF generators use an 
optimized protocol based on progressively reducing the power applied at each pulse when 
power-on periods (tON) cannot be sustained for a minimum period of 10 seconds [3]. Even 
though this optimized protocol can create larger coagulation zones than a simple pulsing 
protocol, to date no computer model has reached this level of detail. Secondly, the 
impedance-controlled protocol was initially described using constant-current pulses [3] 
rather than voltage pulses. In spite of this, we have observed in previous experimental studies 
that the RF generator really applies either current pulses or constant voltage pulses in the 
same RFA, probably depending on the tissue impedance encountered. This means it is also 
necessary to study the differences between models based on voltage pulses and those based 
on current pulses. 
Our objective was thus to build RFA models that included an impedance-controlled 
pulsing protocol similar to that implemented in current RF generators in order to study the 
differences between voltage and current pulses and to compare the computer results with 





Description of the model 
We considered the Cool-tipTM (Covidien, Boulder, CO, USA), a conventionally cooled, 
needle-like, 17G electrode (1.5 mm diameter) with a 3 cm active tip. It is internally cooled 
by chilled saline to keep electrode temperature below 10-15ºC [13]. We assumed that the 
electrode was completely inserted in hepatic tissue, as shown in Figure 1. The problem 
presents axial symmetry and hence a two-dimensional analysis is possible. The dispersive 
electrode was modeled as an electrical condition on outer boundaries at a distance from the 
active electrode. 
 
Governing equations, boundary conditions and material characteristics 
The model was based on a coupled electric-thermal problem, which was solved numerically 
using COMSOL Multiphysics software (COMSOL, Burlington, MA, USA). The governing 
equation for the thermal problem was the bioheat equation modified by the enthalpy method 
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where ρ is tissue density, h enthalpy, k  thermal conductivity, T temperature and t time. The 
term q refers to the heat source from RF power, Qp refers to the blood perfusion heat and Qmet 
refers to the metabolic heat which is negligible in RFA. For biological tissues enthalpy is 
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where ρi and ci are density and specific heat of tissue respectively at temperatures below 
100ºC (i=l) and at temperatures above 100ºC (i=g), hfg is the product of water latent heat of 
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vaporization and water density at 100ºC (2.17×109 J/m3·K), and C is tissue water content 
inside the liver (68%) [15]. The characteristics of materials used in the model are shown in 
Table 1 [1416]. The blood perfusion heat Qp is zero for an ex vivo situation. In an in vivo 
situation Qp is computed from: 
    )( TTcQ bbbbp                                                                  (3) 
where ρb is density of blood, cb specific heat of blood, Tb blood temperature (37ºC), ωb blood 
perfusion coefficient (0.019 s-1) [17] and β is a coefficient which took the values of 0 and 1 
depending on the value of the thermal damage: β=0 for   4.6, and β= 1 for   < 4.6. The 
parameter  is assessed by the Arrhenius damage model [18], which associates temperature 
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where R is the universal gas constant, A (7.39×1039 s-1) is a frequency factor and ΔE 
(2.577×105 J/mol) is the activation energy for the irreversible damage reaction [19]. We 
employed the D99 thermal damage contour to compute the coagulation zone contour 
dimension, which corresponds to Ω = 4.6 (99% probability of cell death). We found that this 
value offers a better prediction of coagulation zone size than Ω = 1 (68% probability of cell 
death) when compared to experimental results. 
The heat source from RF power q (Joule losses) was given by q=|E|2, where E is the 
electric field which was obtained from the electrical problem and σwas electrical 
conductivity. ·σV=0 was the governing equation for the electric problem, V being the 
voltage. The electric field was calculated by means of E = V. We used a quasi-static 
approach due to the resistive current being much higher than displacement current at RF 
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(≈500 kHz) [20]. Electrical conductivity σ is a temperature-dependent piecewise function 
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where σ(37) represents the electrical conductivity assessed at 37ºC (see Table 1). Initial and 
boundary temperatures were 37ºC and 21ºC for the in vivo and ex vivo situations, 
respectively. The cooling effect of the liquid circulating inside the electrode was modeled 
using a thermal convection coefficient hr with a value of 3,127 W/K·m2 and a coolant 
temperature of 5ºC, following Newton’s law of cooling. The value of hr was calculated by 
considering the electrode length (3 cm) and a flow rate of 45 mL/min through an area 
equivalent to half the cross section of the inner diameter of the electrode. Tissue boundary 
conditions were set at electrical insulation, except the bottom and top surfaces, which were 
set at V=0, since they represent the dispersive electrode. Once roll-off occurs, power is 
switched off for 15 s and then a new energy pulse is applied until the next roll-off [3]. This 
procedure, common in clinical practice, is repeated for a period of 12 minutes.  
Current and voltage pulses were applied to the electrode as boundary conditions. In the 
case of voltage pulses, impedance was evaluated (at any time) as a ratio between the applied 
voltage constant value and the total current flowing, which was computed by integrating the 
current density on the surfaces with a boundary condition of 0 V. For current pulses, 
impedance was evaluated (at any time) as a ratio between the value voltage computed at a 
point on the active electrode and the applied current constant value. 
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The model mesh was heterogeneous, with a finer mesh size at the electrode-tissue interface, 
where the highest electrical and thermal gradients were expected. All the mesh elements used 
were triangular. The size of the finer mesh was estimated by a convergence test. We used the 
value of the maximum temperature (Tmax) reached in the liver at the first roll-off time as a 
control parameter in these analyses. When there was a difference of less than 0.5% in Tmax 
between simulations we considered the former mesh size as appropriate. A similar 
convergence test was used to estimate the optimal outer dimensions. To find the solution to 
time-dependent problem the implicit time-stepping method BDF (backward differentiation 
formulas) was used. BDF method has been used for a long time and is well known for its 
stability. To modify how the time-stepping method selects the time steps, the free option was 
selected, i.e. to choose time steps freely. The MUMPS (multifrontal massively parallel sparse 
direct solver) direct solver method was chosen to solve the linear system equations of the 
FEM problem. To improve the convergence of the multiphysics problem, the Segregated 
algorithm was used. This attribute makes it possible to split the solution process into substeps. 
No preconditioner was needed. The mean run time was 10 hours. 
 All computer simulations were performed on a Dell T7500 workstation with Six Core 
2.66 GHz Xeon processors and 48 GB RAM running on a Windows 7 Professional 64-bit 
operating system. The degrees of freedom in the final simulations of the finer mesh was 
14.010 and the RAM requirements were 13.13 GB: 6.15 GB physical memory + 6.98 GB 
virtual memory. 
 
Variables analyzed and cases considered 
The following outcomes were analyzed: 1) progress of the short (transverse) diameter of the 
coagulation zone, 2) time when first roll-off occurred and time between two consecutive roll-
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offs, and 3) evolution of electrical variables (current, voltage, power, and impedance). 
Moreover, energy was calculated as the integral of power over the simulation time, including 
periods in which power was switch off. Three conditions related to tissue temperature and 
blood perfusion were considered: 1) in vivo without clamping maneuver, which means 
considering the blood perfusion term (Qp in Eq. 1) and assuming a tissue temperature of 37ºC; 
2) in vivo with clamping surgical maneuver in order to stop blood perfusing into the liver 
during RFA, which implies that the Qp = 0 and the tissue temperature is 37ºC; and 3) ex vivo, 
which models a bench-test situation and entails excluding Qp and assuming a tissue 
temperature of 21ºC. 
Both current and voltage pulses were simulated. In the case of current, which seems to be 
the most relevant from the clinical point of view, the three above-mentioned conditions were 
considered. In the case of voltage, ex vivo and in vivo conditions (without clamping) were 
considered for a broad range of voltage values (45-100 V), while in vivo with clamping was 
only simulated with 90 V. The coagulation zone diameters computed with current pulses 
were compared to minor transverse diameters reported in previous experimental studies, 
since it is assumed that RF generators deliver current pulses rather than voltage pulses. Only 
experimental data corresponding to the same electrode design (17G, 3-cm) and same RFA 
duration (12 minutes) were appraised. When the experimental study did not specify the 
current value used, we assumed that the RF generator worked at maximum power (200 W) 
and therefore delivered pulses with a mean value of 1600 mA [13]. 
The procedure proposed in [3] was followed for both current and voltage pulses. In brief, 
we first searched for the level of current or voltage which allowed continuous application 
without the need for pulsing (i.e. without observing roll-off episodes). Pulses with a prefixed 
amplitude large enough to cause roll-offs were then applied, i.e. the pulsing protocol was put 
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to work. Finally, we implemented the optimized pulsing protocol based on pulses with 
variable amplitude and dependent on the duration of the time in which RF is being applied 
(tON), i.e. amplitude was progressively reduced (5 V in the case of voltage pulses and 100 




The value of the current which could be continuously applied for 12 minutes without a rise 
in impedance (roll-off) was 750 mA, regardless of the tissue condition. With this value, the 
coagulation zone diameters were 1.43 cm, 2.40 cm and 3.40 cm in the case of in vivo, ex 
vivo, and in vivo with clamping (i.e. without blood perfusion), respectively. For higher 
current values, roll-off episodes were observed and hence the pulsing protocol came into 
action. However, unlike the case of voltage pulses (see below), the gradual reduction in the 
duration of the pulses (tON) throughout the ablation was much less marked and in fact tON was 
always longer than 10 s, which prevented the optimized protocol being put into operation. 
Table 2 shows the coagulation zone diameters for different current values and tissue 
conditions. As expected, the coagulation zones were larger without blood perfusion (ex vivo 
and in vivo with clamping). As expected, tissue temperature also affected coagulation zone 
size, since the diameters obtained at 21ºC (ex vivo case) were smaller than at 37ºC (in vivo 
without blood perfusion –BP–). The coagulation zone diameters created under ex vivo 
conditions were 1 cm larger than those created under in vivo conditions with BP and 1 cm 
smaller than those created under in vivo conditions without BP. The effect of increasing 
current from 1500 mA to 2000 mA on coagulation zone size was more pronounced in the in 
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vivo case without clamping. For comparative purposes, Table 2 also includes the values 
reported in previous experimental studies [3,13,23-26].  
Figure 2 shows the evolution of the electrical variables during an RFA of 1500 mA pulses 
in the in vivo case. Voltage and power in general remained below 100 V and 200 W, 
respectively, except for the brief moments in which roll-offs occurred, which are not 
significant compared to the duration of the ablation. Figure 3 plots the times when the first 
occurred and tON at the end of the RFA for different current values and tissue conditions. 
Time to first roll-off was more or less similar regardless of tissue condition, and increased 
from 13 s to 35 s when current was reduced from 2000 mA to 1500 mA. The tON behavior 
when current changed was more erratic (between 20 and 50 s) but tended to decrease in value 
at higher current values. 
 
Voltage pulses 
The voltage which could be continuously applied for 12 minutes without impedance increase 
(roll-off) was 45 V, regardless of the tissue condition. With this value, the coagulation zone 
diameters were 1.88 cm and 2.5 cm in the in vivo and ex vivo cases, respectively. Roll-off 
episodes were observed at higher voltages, which showed that the pulsing protocol was 
active. Unlike the case of current pulses, the duration of the pulses (tON) got gradually shorter 
throughout the ablation (see Figure 4), which meant that the optimized pulsing protocol had 
acted. Figure 5 shows the evolution of the electrical variables for the optimized protocol with 
initial pulses of 90 V. 
Figure 6 gives the first roll-off time and the tON at the end of the RFA. Times to first roll-
off were in general longer in the ex vivo case and increased dramatically when voltage 
dropped from 100 V to 70 V: from 25 s to 81 s in the in vivo case, and from 40 s to 134 s in 
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the ex vivo case. These values were obviously identical for the non optimized and optimized 
protocol. The tON values tended to decrease when voltage increased, were in general unrelated 
to the voltage level, and were longer for the optimized protocol. 
Table 3 and Figure 7 show the coagulation zone diameters at different voltages and tissue 
conditions for the non optimized and optimized pulsing protocols. No important differences 
in coagulation zone diameters were found between these protocols after 12 minutes of RFA 
for different values of applied voltage over 60 V. The optimized protocol produced a 
coagulation zone diameter 0.2 cm larger in vivo (from 2.4 cm to 2.6 cm) than the non 
optimized protocol. This improvement was much less ex vivo (from 3.25 cm to 3.30 cm). 
Figure 8 shows the time progress of the thermal diameter during a 90 V pulse RFA for the 
three cases: i) in vivo with and ii) without blood perfusion (at 37ºC) and iii) ex vivo (at 21ºC). 
As expected, coagulation zone diameter in vivo was larger when perfusion was not 
considered. The difference with respect to the case with perfusion can be noted 
approximately from second 40. On the other hand, coagulation zone diameter, although 
initially smaller in the ex vivo case, changed this tendency after around 2 minutes and the 
coagulation zone finally created ex vivo (21ºC) was, as expected, larger than in vivo (37ºC). 
In order to explain the differences between voltage and current pulses, we finally analyzed 
the applied energy in each case, and also estimated mean power as the ratio between the 
applied energy and the accumulated time for which the energy was really applied, i.e. the 
sum of tON. Table 4 shows the values of energy and mean power for voltage and current 





Comparison between current pulses and voltage pulses 
The simulations in which current pulses were programmed showed interesting differences to 
the case involving voltage pulses. In essence, tON was always longer than 10 s, thus making 
it unnecessary to use the optimized protocol. The number of roll-offs up to 720 seconds of 
RFA was around 15, while there were about 23 with voltage pulses. This last value is more 
in agreement with those obtained in experimental studies (see Fig. 4 in [27] and Fig. 2 in 
[26]). However, the waveforms of the electrical variables obtained when current pulses are 
employed were more similar to those observed in the experiments compared to those created 
with voltage pulses. 
The coagulation zone diameters created with current pulses were larger than those created 
with voltage pulses (e.g. 2.61 cm with 100 V, vs. 2.8 cm with 1500 mA).  There could be 
two reasons for this fact. First, the peak power, which was higher with current pulses (around 
150 W, see Fig. 2) compared to voltage pulses (around 125 W, see Fig. 4). And second, the 
difference in accumulated energy (see Table 4), which is up to three-times higher with current 
pulses because tON is in general longer (see Fig. 2 vs. Figs. 4 and 5; and Fig. 3 vs. Fig. 6). We 
think that the delay in roll-off with constant current (I) is because even though impedance 
(Z) is gradually decreasing during heating, power (P=I2Z) is also dropping and this acts as 
a protecting mechanism which delays overheating and avoids triggering roll-off. 
All the above suggests clinical implications: using current instead of voltage would allow 
larger coagulation zones to be created. In fact, observing the experimental waveforms of the 
electrical variables throughout an RFA, we can conclude that the present RF generators 
normally deliver current pulses rather than voltage pulses. The general performance is as 
follows: RF generators have a maximum power and limited current and voltage. For instance, 
a 200-W power RF generator has limits of 100 V and 2000 mA. With these technical 
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specifications the generator will be able to provide 200 W on a tissue impedance of 50  
(V/I=100 V/2000 mA). However, power will be lower than 200 W when tissue impedance is 
100 , and in these circumstances the voltage will be limited to 100 V, while maximum 
current will be 1000 mA (=100 V/100 ). In general, therefore, tissue impedances higher 
than 50  will imply that the RF generator provides a maximum voltage of 100 V and current 
will depend on the impedance value. In contrast, power will also be lower than 200 W when 
tissue impedance is 40 , for instance, and in these circumstances current will be limited to 
2000 mA, while maximum voltage will be 80 V (=2000 mA40 ). Tissue impedances 
below 50  will imply that the RF generator provides a maximum current of 2000 mA and 
voltage will depend on the impedance value. This means that the same RF generator will 
work with either current or voltage according to the tissue impedance it encounters. Our 
computer results suggest that delivering RF power by current pulses delays roll-off and 
creates larger coagulation zones. A possible way of ensuring this working condition would 
be to reduce tissue impedance, for instance, by saline infusion before heating [28]. 
 
Optimized vs. non optimized pulsing protocol 
Unlike the findings of Goldberg et al [3], the computer results using current pulses showed 
that the optimized protocol was not necessary, since tON was always longer than 10 s. In 
contrast, voltage pulses significantly reduced tON to less than 10 s. As observed in [3], 
coagulation zone diameter was independent of the voltage value (for values higher than 60 
V), with both a non optimized and optimized protocol. Although our results show that the 
optimized protocol can create larger coagulation zones than non optimized, the improvement 
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was much smaller than that reported in [3] with current pulses under ex vivo conditions (0.05 
cm vs. 1.1 cm). 
 
Effect of tissue conditions (blood perfusion and initial temperature) 
With both current and voltage pulses, coagulation zone diameters under ex vivo conditions 
were larger than those created in vivo, and smaller than in vivo without blood perfusion. This 
suggests that both tissue temperature (21ºC vs. 37ºC) and blood perfusion impact on 
coagulation zone size, regardless of whether voltage or current pulses are used. In fact, our 
computer results match well qualitatively with those reported in [23]: 3.3 ± 0.4 cm for ex 
vivo at 22ºC, 1.8 ± 0.5 cm for in vivo at 37ºC, and 4.0 ± 0.6 cm for ex vivo at 37ºC. In the in 
vivo case, our results with and without clamping closely agree with those observed 
experimentally since the coagulation zone diameters were always larger with clamping [29]. 
Surprisingly, our results also showed that in vivo coagulation zones were larger than ex vivo 
at the start of heating (see Fig. 8). We had already observed this fact in previous computer 
and experimental studies involving short durations (20-60 seconds) [30,31]. We believe that 
the initial tissue temperature (room vs. body) could be a conditioning factor right from the 
start of ablation and would be almost the only factor in tissue 1-2 mm away, while the thermal 
sink effect caused by blood perfusion would have almost no effect in the first few seconds 
and would mainly affect distant tissue (> 10 mm [32]), i.e. would not be influenced by direct 
heating. Our computer results seem to confirm this hypothesis. 
 
Comparison with experimental data 
In the computer simulations, the optimized protocol only came into action when voltage 
pulses were programmed. If we assume that the real protocol is based on current pulses, our 
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results do not match with previous experimental results either ex vivo [3] or in vivo [26], 
where a progressive decrease in the amplitude of current pulses is observed. However, the 
computer results with voltage pulses reproduced the findings of Goldberg et al [3] in terms 
of a progressive reduction of tON to values of 2-3 s, and coagulation zone diameters were 
larger when the optimized protocol was used. 
In spite of the disagreement on the necessity for the optimized protocol with current 
pulses, the computed waveforms of the electrical variables with current pulses (see Fig. 2) 
matched well with those reported experimentally [26]. The computed current value which 
could be continuously applied for 12 minutes without roll-off (750 mA) coincided exactly 
with the experimental ex vivo results [3], but not in vivo (1100 mA in [3]). The computed in 
vivo coagulation zone diameter with 1600 mA pulses (3 cm) was between the values obtained 
by Goldberg et al (3.7 cm [3]) and those reported by others (1.8 cm [23]  2.6 cm [13,26]). 
Likewise, the computed ex vivo coagulation zone diameters were in general smaller that 
those reported by Goldberg et al [3] and larger than those reported by others (see Table 2). 
In general, Goldberg et al’s experimental values [3] were the largest of those reported in the 
literature. Our results were always within the range of the reported experimental results. 
Comparing the in vivo computer results using both current (Table 2) and voltage (Table 
3) pulses, with those reported in experimental studies (coagulation zone diameters between 
1.8 and 2.6 cm [13,23,26]), we conclude that in order to model a 12-minute RFA at 200 W 
nominal power, two options could be chosen, both with pros and cons:  
1) Voltage pulses of 100 V: These allow coagulation zone diameters of 2.38 and 2.61 cm to 
be predicted without and with an optimized protocol, respectively, which are very close 
to the reported experimental values. The number of roll-offs during the RFA matches well 
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with those observed experimentally. However, the computed waveforms, especially 
applied power, do not match with the experimental results.  
2) Current pulses of 1600 mA: Programming current pulses achieved a more realistic 
evolution of the electrical variables. As a negative, the coagulation zone diameters 
computed are slightly larger than those reported in most experiments (3 cm vs. 2.6 cm) 
and there are fewer roll-offs than experimentally observed. 
It is important to note that these conclusions are valid when coagulation zones are 
estimated using D99 at a blood perfusion coefficient of 0.019 s-1 [17]. We obtained larger 
coagulation zones with D63 and lower values of blood perfusion coefficient, e.g. 0.003 s-1 
[33]. 
 
Limitations of the study 
Trying to match computer results with experimental results is without doubt a complex task 
due to the many factors involved and the variations in experimental conditions. To date, 
computer studies on RFA have examined the effect of specific factors related to the procedure 
and different modeling approaches [4-11]. None have focused on a direct comparison of 
different experimental results in terms of coagulation zone size and the evolution of electrical 
variables. The task is even harder if clinical results are used, since they can vary immensely, 
from 1.7 to 5.3 cm [34]. This is possibly due to variations in tissue characteristics and 
procedural factors, such as multiple applications of RF power on the same target to increase 
total coagulation zone size by overlapping. 
We must also point out a technical detail: the computer simulations with voltage pulses 
could only be run with a direct solver, while those with current pulses could be run with the 
iterative solver. Another option was not possible due to convergence problems at the first 
18 
 
roll-off. Both methods are available with COMSOL to solve systems of linear equations, 
however while the direct solvers use more memory than the iterative solvers and are more 
robust, iterative solvers approach the solution gradually and hence have fewer convergence 
problems. Unfortunately, we were not able to compare both methods with the same pulse 
type (voltage or current). However, we found that both methods showed identical solutions 
in terms of coagulation zone size, at least until the arrival of the first roll-off. 
The goal of this study was to set a computational model to mimic the impedance-
controlled pulsing protocol implemented in RF generators used for clinical practice of 
radiofrequency ablation (RFA). For this reason, and in spite that it is clearly out of the scope 
of this study, we could comment about how the model parameters could be obtained in a 
specific patient in order to plan the treatment. The high number of model parameters, along 
with some of the parameters’ temperature dependence, suggests that it is still difficult to run 
in a reasonable period of time a realistic simulation based on a patient-specific setting with 
the currently available computer resources. Despite this, we could suggest that the electrical 
conductivity could be estimated indirectly from pre-RFA impedance measurement. Also 
prior to RFA, blood perfusion and thermal characteristics could be indirectly estimated from 
measurements of the electrode temperature response (without internal cooling) following the 
application of low-power brief RF pulses, as proposed in [35,36]. 
 
Conclusions 
The proposed model reflects electrical-thermal performance during an impedance-controlled 
pulsing protocol reasonably well. Differences between voltage and current pulses protocol 
are noticeable: using current instead of voltage would allow larger coagulation zones to be 
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created. If voltage pulses are employed, the model can accurately predict number of roll-offs, 
although the waveform of the applied power is clearly not realistic. If current voltages are 
employed, the applied power waveform matches well with those reported experimentally, 
but there are significantly fewer roll-offs. Even though the size of the coagulation zone 
reported in previous experimental studies varies widely, our computer results are within the 
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Table 1. Characteristics of the materials used in the theoretical model [1416]. 
 
 
Material ρ (kg/m3) c (J/kg·K) k (W/m·K) σ (S/m) 
Liver 1080 (1) 3455 (1) 0.502 0.19 (3) 
370 (2) 2156 (2)
Electrode 8×103 480 15 7.4×106 
Plastic 70 1045 0.026 1×10-5 
Blood 1000 3639   
ρdensity; c, specific heat; k, thermal conductivity; σelectric conductivity; 









Table 2. Coagulation zone diameters (in cm) computed (FEM) for different current values and tissue 
conditions (temperature and blood perfusion –BP–). Values reported in previous experimental studies 
are also included [3,13,24-26]. 
Current 
(mA) 
In vivo  
(37ºC, with BP) 
Ex vivo  
(21ºC, without BP) 
In vivo (37ºC, 
without BP) 
FEM Experimental FEM Experimental FEM 
2000 3.30 3.6 [13] 4.10 4.6 [13] 5.25 
1800 3.12  4.10 4.6 [3] 5.20 
1600# 3.00 
3.7 [3]     2.6 [13] 
1.8 [23]    1.85 [24] 





1500 2.80  3.88 4.3 [3,13] 4.90 
750* 1.43  2.40 2.9 [3] 3.40 
* Value which could be continuously applied for 12 minutes without a rise in impedance. #Mean 








Table 3. Coagulation zone diameters (in cm) computed for different voltage values and tissue 
conditions. 
Voltage (V) In vivo (37ºC) Ex vivo (21ºC) 
Non optimized 
pulsing protocol 
100 2.38 3.25 
90 2.40 3.25 
80 2.40 3.25 
70 2.35 3.27 
60 2.40 3.25 
50 2.25 3.18 
45* 1.88 2.50 
Optimized 
pulsing protocol 
100 2.61 3.32 
90 2.60 3.29 
80 2.68 3.30 
70 2.60 3.31 









Table 4. Comparison between voltage and current pulses in terms of electrical parameters and 
coagulation zone diameters (in vivo case, 37ºC, with blood perfusion). 
 
Energy (kJ) Mean power* 
(W) 
Current (mA) 
2000 68.3 217 
1800 67.3 173 
1600 64.6 135 
1500 58.7 122 





100 22.0 122 
90 24.0 104 
80 25.6 87 
70 26.5 69 
60 26.5 50 
50 23.7 34 





100 26.5 78 
90 26.7 77 
80 26.8 76 
70 27.1 67 















Figure 1 Geometry of the model used in the study (out of scale, dimensions in mm). The 
outer dimensions (60 mm wide and 150 mm long) were calculated by means of a 
convergence test (see text for more details). The active electrode is labeled as 
“electrode” while the dispersive electrode is really modeled as a boundary condition 











Figure 2 Evolution of voltage, impedance and power during a 12-minute RFA using pulses 












Figure 3 Effect of amplitude of current pulses and tissue conditions on the time of first roll-












Figure 4 Current, impedance and power evolution during a 12-minute RFA using 90 V 











Figure 5 Voltage, current, impedance and power evolution during a 12-minute RFA using 
90 V pulses and an optimized pulsing protocol (in vivo plots). Note that the 
amplitude of the voltage pulses progressively decreased from 90 V to 65 V in order 














Figure 6 Effect of voltage amplitude on the time of first roll-off and tON at the end of the 12-












Figure 7 Coagulation zone diameters at different voltages in vivo at 37ºC and ex vivo at 









Figure 8  Evolution with time of thermal diameter throughout 12 minutes of RFA for three 
cases in which 90 V pulses were applied in an impedance-controlled mode: in vivo 
with and without blood perfusion and tissue temperature of 37ºC, and ex vivo 
(without blood perfusion and tissue temperature of 21ºC). Note that the coagulation 
zone is initially larger in vivo (37ºC) than ex vivo (21ºC), but this tendency changes 
at the point signaled by the arrow. 
 
 
 
 
 
